Product Information
VENLAFAXINE HCL 50 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0979 per EA under NDC 68382002001. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382002001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077653On Market Since
6/13/2008
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 50 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 73.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0979 per EA |
|---|---|
| All-time high | $0.4798 (Feb 12, 2014) |
| All-time low | $0.0537 (Jan 18, 2023) |
| 52-week high | $0.0979 |
| 52-week low | $0.0797 |
| Median price | $0.1987 |
| Average price | $0.2057 |
| Largest weekly change | +66.0% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 50 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0979 per EA (NDC 68382002001), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 50 MG TABLET has declined 73.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 50 MG TABLET?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL 50 MG TABLET has ranged from a low of $0.0537 (Jan 18, 2023) to a high of $0.4798 (Feb 12, 2014), with a median of $0.1987 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 50 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL 50 MG TABLET, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 50 MG TABLET?
VENLAFAXINE HCL 50 MG TABLET (NDC 68382002001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification